title: [Fluconazole--a new antifungal agent].
abstract: Fluconazole (Diflucan) is a new triazole antifungal agent that is effective against a wide range of fungi and has a favourable pharmacokinetic profile. Fluconazole is absorbed well after oral intake independent of food intake. Fluconazole is given once daily, in a dose of 50-400 mg. The dosage is the same for oral and parenteral administration. Tissue penetration is good, as is the concentration in cerebrospinal fluid. Fluconazole should not be given to children under 16 years of age, nor to pregnant or breast-feeding women. In Norway, fluconazole is indicated for treatment of candida vaginitis that is resistant to other treatment, invasive candida infection, candida stomatitis in immunocompromised hosts, and cryptococcal meningitis.
authors.affiliation: Infeksjonsmedisinsk avdeling, Ullevål sykehus, Oslo.
authors.forename: J H
authors.initials: JH
authors.lastname: Dobloug
mesh_terms: D002177:Candidiasis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D015725:Fluconazole / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans
chemical_list: D015725:Fluconazole
vernacular_title: Flukonazol--et nytt antimykotikum.